Initial use of fixed-dose angiotensin receptor blocker/hydrochlorothiazide therapy may improve hypertension management, reduce risk of cardiovascular disease, and decrease long-term healthcare expenditures.
Amy M. Egras, PharmD, BCPS
Advertisement
Articles by Amy M. Egras, PharmD, BCPS
Advertisement
Latest Updated Articles
- Reduced Cardiovascular Risk and Healthcare Expenditures With Angiotensin Receptor Blocker/ Hydrochlorothiazide
Published: April 27th 2010 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
2
Current and Emerging BCMAxCD3 Bispecifics
3
Same Pathway, Different Profiles: Clinical Considerations for Alpelisib, Capivasertib, and Inavolisib
4
Evolocumab Reduces Risk of Major Events in Patients Without Prior Cardiovascular History
5
